Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Solid Biosciences Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 92 | 1 | 91 | 0 |
| Shares | 80.2M | 76.2K | 77.0M | −3.14M (−3.9%) |
| Value | $293.4M | $279.0K | $184.3M | −$108.8M (−37.1%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Solid Biosciences Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 100,612 | $240.0K | 0.02% |
| Franklin Resources Inc | 76,200 | $182.0K | 0.00% |
| Boothbay Fund Management, LLC | 59,775 | $143.0K | 0.01% |
| SG Americas Securities, LLC | 35,688 | $85.0K | 0.00% |
| HSBC Holdings PLC | 29,935 | $72.0K | 0.00% |
| IPG Investment Advisors LLC | 17,900 | $42.8K | 0.01% |
| Wolverine Trading, LLC | 13,741 | $33.0K | 0.00% |
| Group One Trading, L.P. | 12,946 | $31.0K | 0.00% |
| Prudential Financial Inc | 10,471 | $25.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 10,046 | $24.0K | 0.00% |
| Manchester Capital Management LLC | 10,000 | $24.0K | 0.00% |
| Newman Dignan & Sheerar, Inc. | 10,023 | $24.0K | 0.01% |
| Parallel Advisors, LLC | 291 | $1.00K | 0.00% |
| Ellevest, Inc. | 115 | $0 | 0.00% |
| Quadrant Capital Group LLC | 207 | $0 | 0.00% |
Sold out (15)
Institutions that held Solid Biosciences Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| First Trust Advisors LP | 154,019 | $564.0K |
| Qube Research & Technologies Ltd | 99,101 | $363.0K |
| Russell Investments Group, Ltd. | 76,247 | $279.0K |
| Cubist Systematic Strategies, LLC | 68,194 | $250.0K |
| Assenagon Asset Management S.A. | 42,600 | $156.0K |
| Jane Street Group, LLC | 37,130 | $136.0K |
| Acadian Asset Management LLC | 21,921 | $80.0K |
| Jump Financial, LLC | 17,824 | $65.0K |
| Dynamic Technology Lab Private Ltd | 16,251 | $59.0K |
| ProShare Advisors LLC | 15,469 | $57.0K |
| Windsor Creek Advisors, LLC | 15,000 | $55.0K |
| Squarepoint Ops LLC | 13,321 | $49.0K |
| Point72 Hong Kong Ltd | 3,534 | $13.0K |
| Signaturefd, LLC | 433 | $2.00K |
| Meeder Asset Management Inc | 67 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Solid Biosciences Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 76,200 | $279.0K |